BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17689597)

  • 1. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
    Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
    J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS; Thyagarajan R; Sundström M; Lejon K
    Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TACI attenuates antibody production costimulated by BAFF-R and CD40.
    Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
    Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
    Frasca D; Riley RL; Blomberg BB
    Exp Gerontol; 2007 Mar; 42(3):192-203. PubMed ID: 17067770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells.
    Jabara HH; Geha RS
    J Allergy Clin Immunol; 2005 Apr; 115(4):856-63. PubMed ID: 15806010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of common variable immunodeficiency.
    Castigli E; Geha RS
    J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40.
    Diaz-Sanchez D; Chegini S; Zhang K; Saxon A
    J Immunol; 1994 Jul; 153(1):10-20. PubMed ID: 7515920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.
    Almejun MB; Cols M; Zelazko M; Oleastro M; Cerutti A; Oppezzo P; Cunningham-Rundles C; Danielian S
    Eur J Immunol; 2013 Mar; 43(3):805-14. PubMed ID: 23225259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
    Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
    Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI regulates IgA production by APRIL in collaboration with HSPG.
    Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
    Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27⁻) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen.
    Matsuda Y; Haneda M; Kadomatsu K; Kobayashi T
    Cell Immunol; 2015 Jun; 295(2):127-36. PubMed ID: 25880104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-21 stimulates B-cell immunoglobulin E synthesis in human beings concomitantly with activation-induced cytidine deaminase expression and differentiation into plasma cells.
    Kobayashi S; Haruo N; Sugane K; Ochs HD; Agematsu K
    Hum Immunol; 2009 Jan; 70(1):35-40. PubMed ID: 19026702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
    Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
    J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.